Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03480204 · ClinicalTrials.gov registry record

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

A clinical trial of Cardiac Arrhythmia, sponsored by The Cleveland Clinic.

Completed
Registry status
25
Enrollment target
1
Study location

NCT03480204: Completed study of Cardiac Arrhythmia, sponsored by The Cleveland Clinic.

NCT03480204 is a study of Cardiac Arrhythmia that has completed, run by The Cleveland Clinic. The registered enrollment target is 25 participants, below the 211-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03480204, a study of Cardiac Arrhythmia, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the feasibility and usability of a wearable patch as a cardiac monitor for non-ICU hospitalized patients.

Primary Outcome

Successful patch application by nursing, and transmission of cardiac waveform data to gateway and then to offline secure server

Conditions Studied

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-03-19
Est. Completion 2018-12-23
The Cleveland Clinic

688 total trials

What the finished NCT03480204 record still lists

NCT03480204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 211-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 0 interventions.

NCT03480204 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT03480204 about?

NCT03480204 is a clinical study titled "Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY". This study evaluates the feasibility and usability of a wearable patch as a cardiac monitor for non-ICU hospitalized patients.

What is the current status of trial NCT03480204?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-03-19. Estimated completion is 2018-12-23.

What conditions does trial NCT03480204 study?

This clinical trial studies the following conditions: Cardiac Arrhythmia.

Who is sponsoring clinical trial NCT03480204?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03480204 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03480204's enrollment target sits among peer trials

25 10th of 12 higher than 3 of 12 other Cardiac Arrhythmia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiac Arrhythmia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03480204, the US trial registry maintained by the National Library of Medicine. NCT03480204 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.